Clinical Trials Browser

Phase 1/2 × Sezary Syndrome × O(6)-benzylguanine × Clear all

NCT00961220 2018-05-22

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Phase 1/2 Completed

17 enrolled 6 charts

DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous